Baker Bros. Advisors LP Portfolio Holdings

Baker Bros. Advisors LP

  • $9.86 Billion
  • Q2 2025

Baker Bros. Advisors LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $9.86 Billion distributed in 89 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Incyte Corp with a value of $2.09B, Bei Gene, Ltd. with a value of $1.99B, Acadia Pharmaceuticals Inc with a value of $925M, Insmed Inc with a value of $776M, and Summit Therapeutics Inc. with a value of $718M.

Examining the 13F form we can see an increase of $1.47B in the current position value, from $8.39B to 9.86B.

Baker Bros. Advisors LP is based out at New York, NY

Below you can find more details about Baker Bros. Advisors LP portfolio as well as his latest detailed transactions.

Portfolio value $9.86 Billion
Healthcare: $9.86 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.94B
$6.31 Million 0.06% of portfolio
189,866
Q2 2025 New
$463M
$5.27 Million 0.05% of portfolio
670,431
Q3 2024 Added 22.92%
$37.7M
$4.59 Million 0.05% of portfolio
4,096,210
Q2 2025 Added 0.02%
$403M
$4.01 Million 0.04% of portfolio
1,160,117
Q2 2023 Added 308.49%
$31.6M
$4.04 Million 0.04% of portfolio
2,784,792
Q2 2022 Added 95.42%
$578M
$2.73 Million 0.03% of portfolio
542,539
Q1 2025 Reduced 49.98%
$91.2M
$2.78 Million 0.03% of portfolio
2,485,018
Q2 2025 Reduced 23.74%
$183M
$1.8 Million 0.02% of portfolio
355,112
Q2 2025 Reduced 85.43%
$34.6M
$1.63 Million 0.02% of portfolio
536,832
Q2 2024 Added 168.86%
$734M
$2.24 Million 0.02% of portfolio
344,063
Q3 2024 New
$220M
$1.35 Million 0.01% of portfolio
552,079
Q2 2025 Reduced 49.68%
$239M
$622,000 0.01% of portfolio
1,944,945
Q3 2024 Added 61.14%
$0
$16,000 0.0% of portfolio
833,333
Q3 2021 New
Contineum Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q2 2024 New
Tectonic Therapeutic, Inc.
-
$0 0.0% of portfolio
-
Q1 2025 New
Kiniksa Pharmaceuticals International, PLC
-
$0 0.0% of portfolio
-
Q2 2025 Added 0.23%
V Tv Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q1 2024 New
Cidara Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q2 2025 New
Hookipa Pharma Inc.
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 90.0%
Aligos Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q3 2024 New
Alumis Inc.
-
$0 0.0% of portfolio
-
Q2 2024 New
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 56.87%
Structure Therapeutics Inc.
-
$0 0.0% of portfolio
-
Q2 2025 Added 593.86%
Neumora Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q2 2024 Added 63.22%
Neurogene Inc.
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 33.27%
Opthea Limited
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 3.97%
Praxis Precision Medicines, Inc.
-
$0 0.0% of portfolio
-
Q2 2025 Added 107.97%
Grail, Inc.
-
$0 0.0% of portfolio
-
Q4 2024 New
Rapport Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q2 2025 New
Enliven Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q1 2024 New
Disc Medicine, Inc.
-
$0 0.0% of portfolio
-
Q2 2025 Added 337.44%
Sagimet Biosciences Inc.
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 31.04%
Dianthus Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q2 2025 New
Sionna Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q1 2025 New
Skye Bioscience, Inc.
-
$0 0.0% of portfolio
-
Q4 2024 Added 1.12%
Spyre Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q2 2025 New
Dbv Technologies S.A.
-
$0 0.0% of portfolio
-
Q4 2024 New
Kala Bio, Inc.
-
$0 0.0% of portfolio
-
Q4 2024 Added 34.84%

Summary

  • Portfolio
  • No. of Stocks 89
  • Current Value $9.86 Billion
  • Prior Value $8.39 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 12 stocks
  • Additional Purchases 23 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email